Details of the Drug Reposition

General Information of This Drug (ID: DM3SPY9)

Drug Name
BTI-410   DM3SPY9
Drug Type
Peptide

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Type-1 diabetes DIS7HLUB 5A10 Phase 1 [1]
Type-2 diabetes DIS3X247 5A11 Phase 1 [1]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of Boston Therapeutics.